Population Effectiveness of Dolutegravir Implementation in Sub-Saharan Africa: A Prospective Observational Cohort Study
Condition: HIV-1-infection Intervention: Other: This is an observational study only. Sponsors: Massachusetts General Hospital; Africa Health Research Institute; Mbarara University of Science and Technology; National Institute of Allergy and Infectious Diseases (NIAID); Wellcome Trust; ViiV Healthcare; Harvard Medical School; University of KwaZulu; E mory University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: African Health | Allergy | Allergy & Immunology | Hospitals | Infectious Diseases | Research | Study